Dreamfold
Dreamfold is transforming drug discovery by applying generative machine learning to explore the protein universe and unlock new treatments.

Milestones
Investment year
Investment stage
Investment status
Deal team
Tom Henriksson
Dreamfold is pioneering generative machine learning techniques to navigate the vast landscape of proteins, with the goal of discovering breakthrough medicines. Their work lies at the intersection of machine learning, molecular simulation, and synthetic biology. Founded by researchers from Yoshua Bengio’s lab alongside Michael Bronstein, a leading AI professor at the University of Oxford, Dreamfold is driven by a mission to bring hope to millions of patients who currently have no cure.